A reactive oxygen species-mediated, self-perpetuating loop persistently activates platelet-derived growth factor receptor α

Molecular and Cellular Biology

Volumn 34, Issue 1, 2014, Pages 110-122

  Lei, Hetian ^a   Kazlauskas, Andrius ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE;

ARTICLE; AUTOPHAGY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EPIGENETICS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VITREORETINOPATHY; VITREOUS BODY;

ANIMALS; AUTOPHAGY; BLOTTING, WESTERN; CELL LINE; CELLS, CULTURED; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICROSCOPY, CONFOCAL; MITOCHONDRIA; MUTATION; PHOSPHORYLATION; PROTEIN BINDING; RABBITS; REACTIVE OXYGEN SPECIES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TIME FACTORS; TOR SERINE-THREONINE KINASES; VITREOUS BODY;

EID: 84891400992     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00839-13     Document Type: Article

References (74)

1. Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CD, Fletcher JA. 2003. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299:708-710. http://dx.doi.org/10.1126/science.1079666.
2. Hirota S, Ohashi A, Nishida T, Isozaki K, Kinoshita K, Shinomura Y, Kitamura Y. 2003. Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors. Gastroenterology 125:660-667. http://dx.doi.org/10.1016/S0016-5085(03)01046-1.
3. Andrae J, Gallini R, Betsholtz C. 2008. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 22:1276-1312. http://dx.doi.org/10.1101/gad.1653708.
4. Baroni SS, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, Fraticelli P, Sambo P, Funaro A, Kazlauskas A, Avvedimento EV, Gabrielli A. 2006. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N. Engl. J. Med. 354:2667-2676. http://dx.doi.org/10.1056/NEJMoa052955.
5. Lei H, Velez G, Hovland P, Hirose T, Gilbertson D, Kazlauskas A. 2009. Growth factors outside the PDGF family drive experimental PVR. Invest. Ophthalmol. Vis. Sci. 50:3394-3403. http://dx.doi.org/10.1167/iovs.08-3042.
6. Clempus RE, Griendling KK. 2006. Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc. Res. 71:216-225. http://dx.doi.org/10.1016/j.cardiores.2006.02.033.
7. Lambeth JD. 2004.NOXenzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4:181-189. http://dx.doi.org/10.1038/nri1312.
8. Oakley FD, Abbott D, Li Q, Engelhardt JF. 2009. Signaling components of redox active endosomes: the redoxosomes. Antioxid. Redox Signal. 11:1313-1333. http://dx.doi.org/10.1089/ars.2008.2363.
9. Meng TC, Fukada T, Tonks NK. 2002. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell 9:387-399. http://dx.doi.org/10.1016/S1097-2765(02)00445-8.
10. Tonks NK. 2005. Redox redux: revisiting PTPs and the control of cell signaling. Cell 121:667-670. http://dx.doi.org/10.1016/j.cell.2005.05.016.
11. Rhee SG, Kang SW, Jeong W, Chang TS, Yang KS, Woo HA. 2005. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr. Opin. Cell Biol. 17:183-189. http://dx.doi.org/10.1016/j.ceb.2005.02.004.
12. Choi MH, Lee IK, Kim GW, Kim BU, Han YH, Yu DY, Park HS, Kim KY, Lee JS, Choi C, Bae YS, Lee BI, Rhee SG, Kang SW. 2005. Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 435:347-353. http://dx.doi.org/10.1038/nature03587.
13. Lei H, Kazlauskas A. 2009. Growth factors outside of the platelet-derived growth factor (PDGF) family employ reactive oxygen species/Src family kinases to activate PDGF receptor alpha and thereby promote proliferation and survival of cells. J. Biol. Chem. 284:6329-6336. http://dx.doi.org/10.1074/jbc. M808426200.
14. Giannoni E, Buricchi F, Raugei G, Ramponi G, Chiarugi P. 2005. Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol. Cell. Biol. 25: 6391-6403. http://dx.doi.org/10.1128/MCB.25.15.6391-6403.2005.
15. Kemble DJ, Sun G. 2009. Direct and specific inactivation of protein tyrosine kinases in the Src and FGFR families by reversible cysteine oxidation. Proc. Natl. Acad. Sci. U. S. A. 106:5070-5075. http://dx.doi.org/10.1073/pnas.0806117106.
16. Yoo SK, Starnes TW, Deng Q, Huttenlocher A. 2011. Lyn is a redox sensor that mediates leukocyte wound attraction in vivo. Nature 480:109-112. http://dx.doi.org/10.1038/nature10632.
17. Lei H, Velez G, Kazlauskas A. 2011. Pathological signaling via plateletderived growth factor receptor alpha involves chronic activation of Akt and suppression of p53. Mol. Cell. Biol. 31:1788-1799. http://dx.doi.org/10.1128/MCB.01321-10.
18. Pennock S, Kazlauskas A. 2012. Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses. Mol. Cell. Biol. 32:1955-1966. http://dx.doi.org/10.1128/MCB.06668-11.
19. Bae YS, Sung JY, Kim OS, Kim YJ, Hur KC, Kazlauskas A, Rhee SG. 2000. Platelet-derived growth factor-induced H2O2 production requires the activation of phosphatidylinositol 3-kinase. J. Biol. Chem. 275:10527-10531. http://dx.doi.org/10.1074/jbc.275.14.10527.
20. Gottlieb RA, Carreira RS. 2010. Autophagy in health and disease. 5. Mitophagy as a way of life. Am. J. Physiol. Cell Physiol. 299:C203-C210. http://dx.doi.org/10.1152/ajpcell.00097.2010.
21. Kazlauskas A. 1994. Receptor tyrosine kinases and their targets. Curr. Opin. Genet. Dev. 4:5-14. http://dx.doi.org/10.1016/0959-437X(94)90085-X.
22. Claesson-Welsh L. 1994. Platelet-derived growth factor receptor signals. J. Biol. Chem. 269:32023-32026.
23. Hooshmand-Rad R, Yokote K, Heldin CH, Claesson-Welsh L. 1998. PDGF alpha-receptor mediated cellular responses are not dependent on Src family kinases in endothelial cells. J. Cell Sci. 111:607-614.
24. Gelderloos JA, Rosenkranz S, Bazenet C, Kazlauskas A. 1998. A role for Src in signal relay by the platelet-derived growth factor alpha receptor. J. Biol. Chem. 273:5908-5915. http://dx.doi.org/10.1074/jbc.273.10.5908.
25. Sicheri F, Kuriyan J. 1997. Structures of Src-family tyrosine kinases. Curr. Opin. Struct. Biol. 7:777-785. http://dx.doi.org/10.1016/S0959-440X(97)80146-7.
26. Blake RA, Broome MA, Liu X, Wu J, Gishizky M, Sun L, Courtneidge SA. 2000. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol. Cell. Biol. 20:9018-9027. http://dx.doi.org/10.1128/MCB.20.23.9018-9027.2000.
27. Bazenet C, Kazlauskas A. 1994. The PDGF receptor alpha subunit activates p21ras and triggers DNA synthesis without interacting with rasGAP. Oncogene 9:517-525.
28. Lei H, Rheaume MA, Velez G, Mukai S, Kazlauskas A. 2011. Expression of PDGFRalpha is a determinant of the PVR potential of ARPE19 cells. Invest. Ophthalmol. Vis. Sci. 52:5016-5021. http://dx.doi.org/10.1167/iovs.11-7442.
29. Andrews A, Balciunaite E, Leong FL, Tallquist M, Soriano P, Refojo M, Kazlauskas A. 1999. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 40:2683-2689.
30. Ory DS, Neugeboren BA, Mulligan RC. 1996. A stable human-derivedpackaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. U. S. A. 93:11400-11406. http://dx.doi.org/10.1073/pnas.93.21.11400.
31. Waypa GB, Marks JD, Guzy R, Mungai PT, Schriewer J, Dokic D, Schumacker PT. 2010. Hypoxia triggers subcellular compartmental redox signaling in vascular smooth muscle cells. Circ. Res. 106:526-535. http://dx.doi.org/10.1161/CIRCRESAHA.109.206334.
32. Lei H, Venkatakrishnan A, Yu S, Kazlauskas A. 2007. Protein kinase A-dependent translocation of Hsp90 alpha impairs endothelial nitricoxide synthase activity in high glucose and diabetes. J. Biol. Chem. 282: 9364-9371. http://dx.doi.org/10.1074/jbc. M608985200.
33. Jones SM, Kazlauskas A. 2001. Growth-factor-dependent mitogenesis requires two distinct phases of signalling. Nat. Cell Biol. 3:165-172. http://dx.doi.org/10.1038/35055073.
34. DeMali KA, Whiteford CC, Ulug ET, Kazlauskas A. 1997. PDGFdependent cellular transformation requires either PLC gamma or PI3K. J. Biol. Chem. 272:9011-9018. http://dx.doi.org/10.1074/jbc.272.14.9011.
35. Kypta RM, Goldberg Y, Ulug ET, Courtneidge SA. 1990. Association between thePDGFreceptor andmembersof the src family of tyrosine kinases. Cell 62:481-492. http://dx.doi.org/10.1016/0092-8674(90)90013-5.
36. Baxter RM, Secrist JP, Vaillancourt RR, Kazlauskas A. 1998. Full activation of the platelet-derived growth factor beta-receptor kinase involves multiple events. J. Biol. Chem. 273:17050-17055. http://dx.doi.org/10.1074/jbc.273.27.17050.
37. Lei H, Hovland P, Velez G, Haran A, Gilbertson D, Hirose T, Kazlauskas A. 2007. A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 48:2335-2342. http://dx.doi.org/10.1167/iovs.06-0965.
38. Pennock S, Rheaume MA, Mukai S, Kazlauskas A. 2011. A novel strategy to develop therapeutic approaches to prevent proliferative vitreoretinopathy. Am. J. Pathol. 179:2931-2940. http://dx.doi.org/10.1016/j.ajpath.2011.08.043.
39. Bazenet CE, Gelderloos JA, Kazlauskas A. 1996. Phosphorylation of tyrosine 720 in the platelet-derived growth factor alpha receptor is required for binding of Grb2 and SHP-2 but not for activation of Ras or cell proliferation. Mol. Cell. Biol. 16:6926-6936.
40. Songyang Z, Carraway KLI, Eck MJ, Harrison SC, Feldman RA, Mohammadi M, Schlessinger J, Hubbard SR, Smith DP, Eng C, Lorenzo MJ, Ponder BAJ, Mayer BJ, Cantley LC. 1995. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373: 536-539. http://dx.doi.org/10.1038/373536a0.
41. Songyang Z, Blechner S, Hoaglund N, Hoekstra MF, Piwnica-Worms H, Cantley LC. 1994. Use of an oriented peptide library to determine the optimal substrates of protein kinases. Curr. Biol. 4:973-982. http://dx.doi.org/10.1016/S0960-9822(00)00221-9.
42. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, Neel BJ, Birge RB, Fajardo J, Chou MM, Hanafusa H, Schaffhausen B, Cantley LC. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778. http://dx.doi.org/10.1016/0092-8674(93)90404-E.
43. Hubbard SR. 2004. Juxtamembrane autoinhibition in receptor tyrosine kinases. Nat. Rev. Mol. Cell Biol. 5:464-471. http://dx.doi.org/10.1038/nrm1399.
44. Klinghoffer RA, Sachsenmaier C, Cooper JA, Soriano P. 1999. Src family kinases are required for integrin but not PDGFR signal transduction. EMBO J. 18:2459-2471. http://dx.doi.org/10.1093/emboj/18.9.2459.
45. Lei H, Rheaume MA, Kazlauskas A. 2010. Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy. Exp. Eye Res. 90: 376-381. http://dx.doi.org/10.1016/j.exer.2009.11.003.
46. Sorkin A, Goh LK. 2009. Endocytosis and intracellular trafficking of ErbBs. Exp. Cell Res. 315:683-696. http://dx.doi.org/10.1016/j.yexcr.2008.07.029.
47. Olson LE, Soriano P. 2009. Increased PDGFRalpha activation disrupts connective tissue development and drives systemic fibrosis. Dev. Cell 16: 303-313. http://dx.doi.org/10.1016/j.devcel.2008.12.003.
48. Rosenkranz S, Ikuno Y, Leong FL, Klinghoffer RA, Miyake S, Band H, Kazlauskas A. 2000. Src family kinases negatively regulate platelet-derived growth factor alpha receptor-dependent signaling and disease progression. J. Biol. Chem. 275:9620-9627. http://dx.doi.org/10.1074/jbc.275.13.9620.
49. Lee JH, Budanov AV, Park EJ, Birse R, Kim TE, Perkins GA, Ocorr K, Ellisman MH, Bodmer R, Bier E, Karin M. 2010. Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies. Science 327:1223-1228. http://dx.doi.org/10.1126/science.1182228.
50. Guertin DA, Sabatini DM. 2005. An expanding role for mTOR in cancer. Trends Mol. Med. 11:353-361. http://dx.doi.org/10.1016/j.molmed.2005.06.007.
51. Lee J, Giordano S, Zhang J. 2012. Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem. J. 441:523-540. http://dx.doi.org/10.1042/BJ20111451.
52. Manning BD, Cantley LC. 2003. Rheb fills a GAP between TSC and TOR. Trends Biochem. Sci. 28:573-576. http://dx.doi.org/10.1016/j.tibs.2003.09.003.
53. Li ZY, Yang Y, Ming M, Liu B. 2011. Mitochondrial ROS generation for regulation of autophagic pathways in cancer. Biochem. Biophys. Res. Commun. 414:5-8. http://dx.doi.org/10.1016/j.bbrc.2011.09.046.
54. Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, Yoshimori T, Ohsumi Y, Tokuhisa T, Mizushima N. 2004. The role of autophagy during the early neonatal starvation period. Nature 432:1032-1036. http://dx.doi.org/10.1038/nature03029.
55. Salazar M, Carracedo A, Salanueva IJ, Hernandez-Tiedra S, Lorente M, Egia A, Vazquez P, Blazquez C, Torres S, Garcia S, Nowak J, Fimia GM, Piacentini M, Cecconi F, PandolfiPP, Gonzalez-Feria L, Iovanna JL, Guzman M, Boya P, Velasco G. 2009. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J. Clin. Invest. 119:1359-1372. http://dx.doi.org/10.1172/JCI37948.
56. Sundaresan M, Yu ZX, Ferrans VJ, Sulciner DJ, Gutkind JS, Irani K, Goldschmidt-Clermont PJ, Finkel T. 1996. Regulation of reactiveoxygen-species generation in fibroblasts by Rac1. Biochem. J. 318(Part 2):379-382.
57. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, Lambeth JD. 1999. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401:79-82. http://dx.doi.org/10.1038/43459.
58. Lei H, Velez G, Cui J, Samad A, Maberley D, Matsubara J, Kazlauskas A. 2010. N-acetylcysteine suppresses retinal detachment in an experimental model of proliferative vitreoretinopathy. Am. J. Pathol. 177:132-140. http://dx.doi.org/10.2353/ajpath.2010.090604.
59. Hardwick JS, Sefton BM. 1995. Activation of the Lck tyrosine protein kinase by hydrogen peroxide requires the phosphorylation of Tyr-394. Proc. Natl. Acad. Sci. U. S. A. 92:4527-4531. http://dx.doi.org/10.1073/pnas.92.10.4527.
60. Abe J, Takahashi M, Ishida M, Lee JD, Berk BC. 1997. c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1. J. Biol. Chem. 272:20389-20394. http://dx.doi.org/10.1074/jbc.272.33.20389.
61. Yoshizaki A, Yanaba K, Yoshizaki A, Iwata Y, Komura K, Ogawa F, Takenaka M, Shimizu K, Asano Y, Hasegawa M, Fujimoto M, Sato S. 2010. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis. Arthritis Rheum. 62: 2476-2487. http://dx.doi.org/10.1002/art.27498.
62. Pontrelli P, Rossini M, Infante B, Stallone G, Schena A, Loverre A, Ursi M, Verrienti R, Maiorano A, Zaza G, Ranieri E, Gesualdo L, Ditonno P, Bettocchi C, Schena FP, Grandaliano G. 2008. Rapamycin inhibits PAI-1 expression and reduces interstitial fibrosis and glomerulosclerosis in chronic allograft nephropathy. Transplantation 85:125-134. http://dx.doi.org/10.1097/01.tp.0000296831.91303.9a.
63. Rangan GK, Coombes JD. 2007. Renoprotective effects of sirolimus in non-immune initiated focal segmental glomerulosclerosis. Nephrol. Dial. Transplant. 22:2175-2182. http://dx.doi.org/10.1093/ndt/gfm191.
64. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. 2008. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7:11-20. http://dx.doi.org/10.1016/j.cmet.2007.10.002.
65. Vander Heiden MG, Cantley LC, Thompson CB. 2009. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029-1033. http://dx.doi.org/10.1126/science.1160809.
66. Vousden KH. 2010. Alternative fuel-another role for p53 in the regulation of metabolism. Proc. Natl. Acad. Sci. U. S. A. 107:7117-7118. http://dx.doi.org/10.1073/pnas.1002656107.
67. Pennock S, Kim D, Mukai S, Kuhnle M, Chun DW, Matsubara J, Cui J, Ma P, Maberley D, Samad A, Van Geest RJ, Oberstein SL, Schlingemann RO, Kazlauskas A. 2013. Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenicblinding disease. Am. J. Pathol. 182:1659-1670. http://dx.doi.org/10.1016/j.ajpath.2013.01.052.
68. Brugarolas J, Kaelin WG, Jr. 2004. Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes. Cancer Cell 6:7-http://dx.doi.org/10.1016/j.ccr.2004.06.020.
69. Wang RC, Wei Y, An Z, Zou Z, Xiao G, Bhagat G, White M, Reichelt J, Levine B. 2012. Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science 338:956-959. http://dx.doi.org/10.1126/science.1225967.
70. Ozawa T, Brennan CW, Wang L, Squatrito M, Sasayama T, Nakada M, Huse JT, Pedraza A, Utsuki S, Yasui Y, Tandon A, Fomchenko EI, Oka H, Levine RL, Fujii K, Ladanyi M, Holland EC. 2010. PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas. Genes Dev. 24:2205-2218. http://dx.doi.org/10.1101/gad.1972310.
71. Feng H, Hu B, Liu KW, Li Y, Lu X, Cheng T, Yiin JJ, Lu S, Keezer S, Fenton T, Furnari FB, Hamilton RL, Vuori K, Sarkaria JN, Nagane M, Nishikawa R, Cavenee WK, Cheng SY. 2011. Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRalpha-stimulated glioma tumorigenesis in mice and humans. J. Clin. Invest. 121:4670-4684. http://dx.doi.org/10.1172/JCI58559.
72. Liu KW, Feng H, Bachoo R, Kazlauskas A, Smith EM, Symes K, Hamilton RL, Nagane M, Nishikawa R, Hu B, Cheng SY. 2011. SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans. J. Clin. Invest. 121:905-917. http://dx.doi.org/10.1172/JCI43690.
73. Levine AJ. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331. http://dx.doi.org/10.1016/S0092-8674(00)81871-1.
74. Rosenkranz S, DeMali KA, Gelderloos JA, Bazenet C, Kazlauskas A. 1999. Identification of the receptor-associated signaling enzymes that are required for platelet-derived growth factor-AA-dependent chemotaxis and DNA synthesis. J. Biol. Chem. 274:28335-28343. http://dx.doi.org/10.1074/jbc.274.40.28335.